Cargando…
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
The presence of barriers, such as the blood–brain barrier (BBB) and brain–tumor barrier (BTB), limits the penetration of antineoplastic drugs into the brain, resulting in poor response to treatments. Many techniques have been developed to overcome the presence of these barriers, including direct inj...
Autores principales: | Mo, Francesca, Pellerino, Alessia, Soffietti, Riccardo, Rudà, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657947/ https://www.ncbi.nlm.nih.gov/pubmed/34884457 http://dx.doi.org/10.3390/ijms222312654 |
Ejemplares similares
-
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors
por: Soffietti, Riccardo, et al.
Publicado: (2023) -
Management of Brain and Leptomeningeal Metastases from Breast Cancer
por: Pellerino, Alessia, et al.
Publicado: (2020) -
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
por: Pellerino, Alessia, et al.
Publicado: (2023) -
Targeted Therapies in Rare Brain Tumours
por: Bruno, Francesco, et al.
Publicado: (2021) -
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
por: Pellerino, Alessia, et al.
Publicado: (2018)